Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.43 |
| ▸ | MET | P08581 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL541617 | 1.00 | OPRM1 (0.43) | OPRM1OPRD1OPRK1OPRL1MET | |
| SCHEMBL5081429 | 1.00 | OPRM1 (0.43) | OPRM1OPRD1OPRK1OPRL1MET | |
| SCHEMBL7359458 | 1.00 | OPRM1 (0.43) | OPRM1OPRD1OPRK1OPRL1MET | |
| SCHEMBL4964887 | 1.00 | OPRM1 (0.43) | OPRM1OPRD1OPRK1OPRL1MET | |
| SCHEMBL3711846 | 1.00 | OPRM1 (0.43) | OPRM1OPRD1OPRK1OPRL1MET | |
| SCHEMBL7572979 | 1.00 | OPRM1 (0.43) | OPRM1OPRD1OPRK1OPRL1MET | |
| SCHEMBL30742696 | 0.97 | OPRM1 (0.42) | OPRM1OPRD1OPRK1OPRL1MET | |
| SCHEMBL4613762 | 0.97 | TSHR (0.40) | OPRM1OPRD1OPRK1OPRL1MET | |
| SCHEMBL9891 | 0.97 | TSHR (0.40) | OPRM1OPRD1OPRK1OPRL1MET | |
| SCHEMBL641967 | 0.97 | TSHR (0.40) | OPRM1OPRD1OPRK1OPRL1MET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120190811-A1 | PROCESS FOR THE PREPARATION OF AN ALLYL ALKYL ETHER BY CATALYTIC ALLYLATION | HEXION INC. (FORMERLY KNOWN AS MOMENTIVE SPECIALTY CHEMICALS INC.) | 2012-07-26 | — | — | US | disclosed |
| EP-2393767-A1 | PROCESS FOR THE PREPARATION OF AN ALLY ALKYL EHTER BY CATALYTIC ALLYATION | Momentive Specialty Chemicals Research Belgium S.A. (BE) | 2011-12-14 | — | — | EP | disclosed |
| WO-2010086139-A1 | PROCESS FOR THE PREPARATION OF AN ALLY ALKYL EHTER BY CATALYTIC ALLYATION | RESOLUTION RESEARCH NEDERLAND B.V. (NL) | 2010-08-05 | — | — | WO | disclosed |
| EP-2213644-A1 | Process for the preparation of an allyl alkyl ether by catalyic allylation | Hexion Specialty Chemicals Research Belgium S.A. (BE) | 2010-08-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190811-A1 | PROCESS FOR THE PREPARATION OF AN ALLYL ALKYL ETHER BY CATALYTIC ALLYLATION | ALOX5, APEH, ALKBH5 | OPRM1 1466/4885OPRD1 1717/4885OPRK1 1925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.